Implementing living‐donor pediatric liver transplantation in Southern Vietnam: 15‐year results and perspectives

Background ND2 in Ho Chi Minh City is currently the only public center that performs PLT in Southern Vietnam. In 2005, the first PLT was successfully performed, with support from Belgian experts. This study reviews the implementation of PLT at our center and evaluates the results and challenges. Met...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric transplantation 2024-02, Vol.28 (1), p.e14441-n/a
Main Authors: Tran, Thanh Tri, Ho, Phi Duy, Luu, Nguyen An Thuan, Truong, Thi Yen Nhi, Nguyen, Hong Van Khanh, Bui, Hai Trung, Pham, Ngoc Thach, Tran, Dong A., Pirotte, Thierry, Gurevich, Michael, Reding, Raymond
Format: Article
Language:English
Subjects:
Child
Epstein-Barr virus
Epstein-Barr Virus Infections - complications
Hepatic artery
Herpesvirus 4, Human
Humans
Liver diseases
Liver transplantation
Liver Transplantation - methods
Living Donors
Patients
pediatric liver transplant
Pediatrics
Postoperative Complications - etiology
Posttransplant lymphoproliferative disorders
Retrospective Studies
Sepsis
Survival
Thrombosis
Transplants & implants
Vietnam
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background ND2 in Ho Chi Minh City is currently the only public center that performs PLT in Southern Vietnam. In 2005, the first PLT was successfully performed, with support from Belgian experts. This study reviews the implementation of PLT at our center and evaluates the results and challenges. Methods Implementation of PLT at ND2 required medico‐surgical team building and extensive improvement of hospital facilities. Records of 13 transplant recipients from 2005 to 2020 were studied retrospectively. Short‐ and long‐term complications, as well as the survival rates, were reported. Results The mean follow‐up time was 8.3 ± 5.7 years. Surgical complications included one case of hepatic artery thrombosis that was successfully repaired, one case of colon perforation resulting in death from sepsis, and two cases of bile leak that were drained surgically. PTLD was observed in five patients, of whom three died. There were no cases of retransplantation. The 1‐year, 5‐year, and 10‐year patient survival rates were 84.6%, 69.2%, and 69.2%, respectively. There were no cases of complication or death among the donors. Conclusion Living‐donor PLT was developed at ND2 for providing a life‐saving treatment to children with end‐stage liver disease. Early surgical complication rate was low, and the patient survival rate was satisfactory at 1 year. Long‐term survival decreased considerably due to PTLD. Future challenges include surgical autonomy and improvement of long‐term medical follow‐up with a particular emphasis on prevention and management of Epstein–Barr virus‐related disease.
ISSN:1397-3142
1399-3046
1399-3046
DOI:10.1111/petr.14441